Product Information
BENZTROPINE MES 0.5 MG TAB is a generic product labeled by Major Pharmaceuticals, priced at $0.0647 per EA under NDC 00904728861. Its NADAC has been published 154 times since Oct 25, 2023.
FDA first approved this application on Aug 27, 2007. Its Orange Book therapeutic-equivalence code is AA.
Strength
.5 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904728861
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BENZTROPINE MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA040715FDA Approved
8/27/2007
TE Code
AA
On Market Since
7/11/2023
Pharmacological Classes
Price Statistics
The NADAC for BENZTROPINE MES 0.5 MG TAB has been published 154 times since Oct 25, 2023, and over the history we have for it it has declined 20.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0647 per EA |
|---|---|
| All-time high | $0.0840 (Feb 14, 2024) |
| All-time low | $0.0629 (May 22, 2024) |
| 52-week high | $0.0731 |
| 52-week low | $0.0633 |
| Median price | $0.0722 |
| Average price | $0.0724 |
| Largest weekly change | +19.6% (Jun 19, 2024) |
| Weeks tracked | 154 |
| Tracking since | Oct 25, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
benztropine mesylate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BENZTROPINE MES 0.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for BENZTROPINE MES 0.5 MG TAB, manufactured by Major Pharmaceuticals, is $0.0647 per EA (NDC 00904728861), effective Sep 30, 2026.
How has the price of BENZTROPINE MES 0.5 MG TAB changed over time?
Over the history we have for it, the NADAC for BENZTROPINE MES 0.5 MG TAB has declined 20.4%. It has been tracked across 154 weekly CMS publications since Oct 25, 2023.
What are the highest and lowest recorded NADAC prices for BENZTROPINE MES 0.5 MG TAB?
Since Oct 25, 2023, the NADAC for BENZTROPINE MES 0.5 MG TAB has ranged from a low of $0.0629 (May 22, 2024) to a high of $0.0840 (Feb 14, 2024), with a median of $0.0722 per EA.
Are there cheaper alternatives to BENZTROPINE MES 0.5 MG TAB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BENZTROPINE MES 0.5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures BENZTROPINE MES 0.5 MG TAB?
BENZTROPINE MES 0.5 MG TAB (NDC 00904728861) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.